<?xml version="1.0" ?>
<document id="19eed2e91c17ea20e9cbda665e19fad13a948ecf">
  <chunk id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c0" text="Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response">
    <entity charOffset="84-93" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c0.e0" ontology_id="CHEBI_22587" text="Antiviral" type="chemical"/>
  </chunk>
  <chunk id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1" text="Cellular receptor-mediated signaling pathways play critical roles during the initial immune response to Human Cytomegalovirus (HCMV) infection. However, the involvement of type-I transmembrane glycoprotein CD147/EMMPRIN (extracellular matrix metalloproteinase inducer) in the antiviral response to HCMV infection is still unknown. Here, we demonstrated the specific knockdown of CD147 significantly decreased HCMV-induced activation of NF-κB and Interferon-beta (IFN-β), which contribute to the cellular antiviral responses. Next, we confirmed that HCMV-encoded miR-US25-1-5p could target the 3 UTR (Untranslated Region) of CD147 mRNA, and thus facilitate HCMV lytic propagation at a low multiplicity of infection (MOI). The expression and secretion of Cyclophilin A (sCyPA), as a ligand for CD147 and a proinflammatory cytokine, were up-regulated in response to HCMV stimuli. Finally, we confirmed that CD147 mediated HCMV-triggered antiviral signaling via the sCyPA-CD147-ERK (extracellular regulated protein kinases)/NF-κB axis signaling pathway. These findings reveal an important HCMV mechanism for evading antiviral innate immunity through its encoded microRNA by targeting transmembrane glycoprotein CD147, and a potential cause of HCMV inflammatory disorders due to the secretion of proinflammatory cytokine CyPA.">
    <entity charOffset="193-205" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e0" ontology_id="CHEBI_17089" text="glycoprotein" type="chemical"/>
    <entity charOffset="276-285" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e1" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="504-513" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e2" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="781-787" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e3" ontology_id="CHEBI_52214" text="ligand" type="chemical"/>
    <entity charOffset="934-943" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e4" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="1003-1010" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e5" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="1112-1121" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e6" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="1194-1206" id="19eed2e91c17ea20e9cbda665e19fad13a948ecf.c1.e7" ontology_id="CHEBI_17089" text="glycoprotein" type="chemical"/>
  </chunk>
</document>
